Concepedia

Author

Kaitlyn K.H. Goey

Utrecht UniversityORCID

Also Known As

K. Goey, K.K.H. Goey, Kaitlyn Goey, Kaitlyn K H Goey, Kaitlyn K. H. Goey, Kaitlyn K.H. Goey

16

Publications

267

Citations

8

H-Index

15

Concepts

All Affiliations

Utrecht UniversityUniversity Medical Center UtrechtAmsterdam UMC Location University of AmsterdamUniversity of AmsterdamInstitut Hospitalier Franco Britannique
KK

About

Kaitlyn K.H. Goey is an author at Utrecht University specializing in oncology, radiation oncology, and colorectal cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

185

2

Surgical Oncology

2

2

107

3

Health Sciences

1

1

33

4

Pathology

1

1

78

5

Pharmacology

1

1

78

Kaitlyn K.H. Goey

×

5

Publications

218

Citations

5

H-Index

YearCitations

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

Kaitlyn K.H. Goey, Sjoerd G. Elias, Harm van Tinteren,

Annals of Oncology

2017

78

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database

Karlijn L. van Rooijen, Qian Shi, Kaitlyn K.H. Goey,

European Journal of Cancer

2018

74

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Kaitlyn K.H. Goey, Halfdan Sørbye, Bengt Glimelius,

European Journal of Cancer

2018

33

BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis

Jamila Laoukili, Susanne van Schelven, Emre Küçükköse,

Cell Reports

2022

22

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials

Kaitlyn K.H. Goey, Sjoerd G. Elias, Axel Hinke,

British Journal of Cancer

2017

11

Page 1